| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |